About the Startup
Berlin-based precision oncology startup developing AI-driven biomarker discovery and clinical decision tools. Its Polaris platform combines H&E histology with RNA-Seq to identify prognostic and predictive biomarkers; the first product, Polaris Breast, assesses metastasis risk in early breast cancer and is undergoing regulatory approval in the EU and US.
Frequently Asked Questions
What type of funding round did StratifAI raise?
StratifAI raised a unspecified round.
How much did StratifAI raise in its unspecified?
StratifAI raised $12,500,000 USD in its unspecified.
When did StratifAI raise its unspecified?
StratifAI raised its unspecified on 2025-10-01.
Who invested in StratifAI's unspecified?
The investors in StratifAI's unspecified are: Alven, Heliad, Rubin Ritter, Lars Langusch, Jens Begemann, Debiopharm, Arve Capital, Christoph Haarburger, Picus Capital.
What type of investment was StratifAI's unspecified?
StratifAI's unspecified was a equity investment.